This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Min Deng: Innovator in Cancer Treatment
Introduction
Min Deng is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of cancer research through his innovative work. His research focuses on methods and materials for identifying and treating cancers that exhibit elevated levels of phosphorylated ubiquitin.
Latest Patents
Min Deng holds a patent for "Methods and materials for identifying and treating cancers having elevated levels of phosphorylated ubiquitin." This patent outlines techniques for detecting cancer cells in mammals, including humans, that have an increased level of phosphorylated ubiquitin polypeptides. Specifically, it provides methods for identifying the presence of cancer cells with elevated levels of Y59 phosphorylated ubiquitin polypeptides.
Career Highlights
Min Deng is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research in cancer treatment. His work has the potential to improve diagnostic methods and therapeutic strategies for cancer patients.
Collaborations
Min Deng collaborates with Zhenkun Lou, contributing to the advancement of cancer research and treatment methodologies.
Conclusion
Min Deng's innovative work in cancer research exemplifies the importance of scientific advancements in improving healthcare outcomes. His contributions are paving the way for more effective cancer detection and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile